Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Patient-reported outcomes in clinical trials leading to breast cancer drug approvals: are we making them count?
Journal: Breast cancer research and treatment
Published: June 05, 2026
Receptor discordance between primary tumors and nodal metastases and correlation with the 21-gene recurrence score in early-stage, estrogen receptor-positive, node-positive breast cancer.
Journal: Breast cancer research and treatment
Published: April 28, 2026
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 24, 2026
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 16, 2026
Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment Landscape.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 10, 2026
Incidence, Risk Factors, and Survival Implications of Immune-Related Adverse Events in Patients With Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: March 20, 2026
GLP-1 Targeting Agents Impair Chemoimmunotherapy Effectiveness in Triple-Negative Breast Cancer.
Journal: Research square
Published: January 16, 2026
Safety and clinical outcomes of pembrolizumab standard-interval dosing versus extended-interval dosing in patients with breast cancer.
Journal: The oncologist
Published: August 27, 2025
Breast Cancer Immunotherapy: A Team Science Approach.
Journal: Cancer treatment and research
Published: August 23, 2025
Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy: a multi-institution study.
Journal: Breast cancer research and treatment
Published: August 20, 2025
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.
Journal: Frontiers in oncology
Published: July 19, 2025
New Drugs, New Toxicities: Side Effects of New and Emerging Breast Cancer Therapies.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: July 09, 2025
Last Updated: 09/26/2026